Back
Summit Therapeutics Stock Price Chart
Sponsored
SMMT
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
75
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.55 | Sell |
20-day SMA: | 17.97 | Buy |
50-day SMA: | 13.36 | Buy |
200-day SMA: | 6.72 | Buy |
8-day EMA: | 24.49 | Buy |
20-day EMA: | 19.78 | Buy |
50-day EMA: | 14.83 | Buy |
200-day EMA: | 8.2 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.26 | Buy |
Relative Strength Index (14 RSI): | 64.67 | Buy |
Chaikin Money Flow: | -4213296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.3 - 23.18) | Buy |
Bollinger Bands (100): | (4.28 - 15.36) | Buy |
Summit Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 24.55 while SMMT 8-day simple moving average is 25.55, which is a Sell signal.
- The stock price of SMMT is 24.55 while Summit Therapeutics 20-day SMA is 17.97, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 13.36 while SMMT share price is 24.55, making it a Buy technically.
- SMMT stock price is 24.55 and Summit Therapeutics 200-day simple moving average is 6.72, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
75
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $24.55. The Score for SMMT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
18.04B
Price in USD:
24.55
Share Volume:
7.41M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Buy
75
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 24.55 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 24.55 while SMMT 8-day exponential moving average is 24.49, which is a Buy signal.
- The stock price of SMMT is 24.55 while Summit Therapeutics 20-day EMA is 19.78, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 14.83 while SMMT share price is 24.55, making it a Buy technically.
- SMMT stock price is 24.55 and Summit Therapeutics 200-day simple moving average is 8.20, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 4.26, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 64.67, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is (10.3 - 23.18), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (4.28 - 15.36), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.